SLC5A2 and diabetic kidney disease: As the effectiveness of SGLT2 inhibition is dependent on the creatinine clearance with decreased efficiency as creatinine clearance decreases we would expect the efficacy to decrease as the severity of diabetic nephropathy increases [23].